1887

Abstract

The organization of epitopes on the minor capsid protein L2 of human papillomavirus (HPV) type 33 has been analysed using three monoclonal antibodies (MAbs) generated against a large fragment of the L2 protein (amino acids 82–259) expressed as a glutathione -transferase fusion protein. The topology of the L2 epitopes has been investigated with respect to the structure of HPV-33 virus-like particles (VLPs). Two of the MAbs reacted with linear epitopes which were mapped to amino acids 153–160 and 163–170, respectively. These epitopes were accessible in denatured but not in native VLPs consisting of L1 and L2, suggesting an internal location. The third antibody was unable to detect denatured L2 protein but reacted with native VLPs. This is the first demonstration of an apparent conformational epitope of the HPV L2 protein. A model for the putative orientation of L2 in the papillomavirus capsid is deduced from the location of these and other antigenic sites.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-11-2661
1995-11-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/11/JV0760112661.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-11-2661&mimeType=html&fmt=ahah

References

  1. Baker T. S., Newcomb W. W., Olson N. M., Cowsert L. M., Olson C., Brown J. C. 1991; Structures of bovine and human papillomaviruses: analysis by cryoelectron microscopy and threedimensional image reconstruction. Journal of Biophysics 60:1445–1456
    [Google Scholar]
  2. Beiss B. K., Heimer E., Felix A., Burk R. D., Ritter D. B., Mallon R. G., Kadish A. S. 1991; Type-specific and crossreactive epitopes in human papillomavirus type 16 capsid proteins. Virology 184:460–464
    [Google Scholar]
  3. Campo M. S., Grindlay G. J., O’Neil B. W., Chandrachud L. M., McGarvie G. M., Jarett W. F. H. 1993; Prophylactic and therapeutic vaccination against a mucosal papillomavirus. Journal of General Virology 74:945–953
    [Google Scholar]
  4. Carter J. J., Hagensee M., Taflin M. C., Lee S. K., Koutsky L. A., Galloway D. A. 1993; HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. Virology 195:456–462
    [Google Scholar]
  5. Christensen N. D., Kreider J. W., Cladel N. M., Patrick S. D., Welsh P. A. 1990a; Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. Journal of Virology 64:5678–5681
    [Google Scholar]
  6. Christensen N. D., Kreider J. W., Cladel N. M., Galloway D. A. 1990b; Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins. Virology 175:1–9
    [Google Scholar]
  7. Christensen N. D., Kreider J. W., Kan N. C., DiAngelo S. L. 1991; The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. Virology 181:572–579
    [Google Scholar]
  8. Christensen N. D., Kreider J. W., Shah K. V., Rando R. F. 1992; Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. Journal of General Virology 73:1261–1267
    [Google Scholar]
  9. Cole S. T., Streeck R. E. 1986; Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. Journal of Virology 58:991–995
    [Google Scholar]
  10. Cowsert L. M., Lake P., Jenson A. B. 1987; Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. Journal of the National Cancer Institute 79:1053–1057
    [Google Scholar]
  11. Danos O., Yaniv M. 1983; Structure and function of papillomavirus genomes. Advances in Viral Oncology 3:59–81
    [Google Scholar]
  12. de Villiers E. M. 1989; Heterogeneity of the human papillomavirus group. Journal of Virology 63:4898–4903
    [Google Scholar]
  13. Doorbar J., Gallimore P. H. 1987; Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus la. Journal of Virology 61:2793–2799
    [Google Scholar]
  14. Galfre G., Howe S. C., Milstein C., Butcher G. W., Howard J. C. 1977; Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 266:550–552
    [Google Scholar]
  15. Hagensee M. E., Yaegashi N., Galloway D. A. 1993; Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. Journal of Virology 67:315–322
    [Google Scholar]
  16. Hagensee M. E., Olson N. H., Baker T. S., Galloway D. A. 1994; Three-dimensional structure of vaccinia-produced human papillomavirus type 1 capsids. Journal of Virology 68:4503–4505
    [Google Scholar]
  17. Jenison S. A., Yu X.-P., Valentine J. M., Galloway D. A. 1991; Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. Journal of Virology 65:1208–1218
    [Google Scholar]
  18. Jin X. W., Cowsert L. M., Pilacinski W. P., Jenson A. B. 1989; Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies. Journal of General Virology 70:1133–1140
    [Google Scholar]
  19. Kirnbauer R., Booy F., Cheng N., Lowy D. R., Schiller J. T. 1991; Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences, USA 89:12180–12184
    [Google Scholar]
  20. Kirnbauer R., Taub J., Greenstone H., Roden R., Dürst M., Gissmann L., Lowy D. R., Schiller J. T. 1993; Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. Journal of Virology 67:6929–6936
    [Google Scholar]
  21. Kirnbauer R., Hubbert N. L., Wheeler C. M., Becker T. M., Lowy D. R., Schiller J. T. 1994; A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. Journal of the National Cancer Institute 86:494–499
    [Google Scholar]
  22. Komly C. A., Breitburd F., Croissant O., Streeck R. E. 1986; The L2 open reading frame of human papillomavirus type la encodes a minor structural protein carrying type-specific antigens. Journal of Virology 60:813–816
    [Google Scholar]
  23. Lin Y.-L., Borenstein L. A., Selvakumar R., Ahmed R., Wettstein F. O. 1992; Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. Virology 187:612–619
    [Google Scholar]
  24. Roden R. B. S., Weissinger E. M., Henderson D. W., Booy F., Kirnbauer R., Mushinski J. F., Lowy D. R., Schiller J. T. 1994; Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. Journal of Virology 68:7570–7574
    [Google Scholar]
  25. Rose R. C., Bonnez W., Reichman R. C., Garcea R. L. 1993; Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. Journal of Virology 67:1936–1944
    [Google Scholar]
  26. Rose R. C., Reichman R. C., Bonnez W. 1994; Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. Journal of General Virology 75:2075–2079
    [Google Scholar]
  27. Sapp M., Kraus U., Volpers C., Snijders P. J. F., Walboomers J. M. M., Streeck R. E. 1994; Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. Journal of General Virology 75:3375–3383
    [Google Scholar]
  28. Sapp M., Volpers C., Muller M., Streeck R. E. 1995; Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. Journal of General Virology 76:2407–2412
    [Google Scholar]
  29. Tomita Y., Shirasawa H., Sekine H., Simizu B. 1987; Expression of the human papillomavirus type 6b L2 open reading frame in Escherichia coli: L2-β-galactosidase fusion proteins and their antigenic properties. Virology 158:8–14
    [Google Scholar]
  30. Volpers C., Sapp M., Komly C. A., Richalet-Secordel P., Streeck R. E. 1993; Development of type-specific and crossreactive serological probes for the minor capsid protein of human papillomavirus type 33. Journal of Virology 67:1927–1935
    [Google Scholar]
  31. Volpers C., Schirmacher P., Streeck R. E., Sapp M. 1994; Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200:504–512
    [Google Scholar]
  32. Volpers C., Unckell F., Schirmacher P., Streeck R. E., Sapp M. 1995; Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. Journal of Virology 69:3258–3264
    [Google Scholar]
  33. Yaegashi N., Jenison S. A., Valentine J. M., Dunn M., Taichman L. B., Baker D. A., Galloway D. A. 1991; Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions. Journal of Virology 65:1578–1583
    [Google Scholar]
  34. Yaegashi N., Jenison S. A., Batra M., Galloway D. A. 1992; Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11. Journal of Virology 66:2008–2019
    [Google Scholar]
  35. Zhou J., Sun X. Y., Stenzel D. J., Frazer I. H. 1991; Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185:251–257
    [Google Scholar]
  36. Zhou J., Sun X. Y., Louis K., Frazer I. H. 1994; Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. Journal of Virology 68:619–625
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-11-2661
Loading
/content/journal/jgv/10.1099/0022-1317-76-11-2661
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error